Moneycontrol
    Moneycontrol PRO

    Risedronate Sodium

    Jump to

    • Ind-Swift Labs eyes good volumes on exports to Japan

      Ind-Swift Labs has got a phamaceutical and medical devices agency approval from the Japanese government for two drugs. In an interview with CNBC-TV18, Gopal Munjal, Chairman, Ind-Swift Labs spoke on the approval and the investment the facility would require.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347